BUZZ-CSPC Pharmaceutical falls most in 10 weeks on weak earnings outlook

Reuters11-01

** Shares of CSPC Pharmaceutical Group Ltd fall as much as 13% to HK$5, on track for the biggest one-day pct drop since Aug. 22

** Stock hits lowest since Sept. 23; on course for third consecutive session of decline ** CSPC, with current market value of HK$61.4 bln ($7.88 bln), expects net profit for nine months ended in September to drop 16% Y/Y amid decrease in revenue of finished drugs business in oncology, cardiovascular and nervous system therapeutic areas

** Hang Seng Commerce & Industry Index climbs 1%, healthcare index up 0.7% and Hang Seng Index rises 1%

** Stock down 27.8% YTD

($1 = 7.7757 Hong Kong dollars)

(Reporting by Donny Kwok) ((donny.kwok@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment